The sustainable synthesis of biaryl sartan intermediates has significant potential in the pharmaceutical industry. Herein, nickel catalyzed C(sp²)-H functionalization of aryl amides with aryl bromides has been disclosed and used in synthesis of telmisartan and sartan intermediates. Deuterium exchange, competitive reaction and radical clock experiment support a Ni(II)/Ni(IV) catalytic cycle.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: